Guardant Health, Inc. (GH) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 12.0% on average (either way), rising 5 times and falling 7. EPS beat estimates 3 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-11-05 | -0.29 | -0.75 | +61.3% | 361.0M | 350.7M | -10.5% |
| Q3 FY2026 | 2026-07-30 | -0.90 | -0.76 | -18.1% | 335.0M | 314.2M | +12.4% |
| Q2 FY2026 | 2026-05-07 | -0.85 | -0.81 | -5.5% | 301.7M | 279.2M | +3.7% |
| Q1 FY2026 | 2026-02-19 | -1.00 | -0.77 | -30.4% | 281.3M | 272.4M | -4.0% |
| Q4 FY2025 | 2025-10-29 | -0.74 | -0.79 | +6.3% | 265.2M | 235.6M | +32.8% |
| Q3 FY2025 | 2025-07-30 | -0.80 | -0.74 | -8.0% | 232.1M | 211.5M | -5.4% |
| Q2 FY2025 | 2025-04-30 | -0.77 | -0.78 | +1.3% | 203.5M | 190.1M | -1.3% |
| Q1 FY2025 | 2025-02-20 | -0.90 | -0.75 | -20.0% | 201.8M | 192.1M | -12.5% |